| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |